BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
HDFC Bank
HDB
$120B
| $226M | 0.01% |
6,179,836
-1,119,874
| -15% | -$41.5M |
|
1627
Vir Biotechnology
VIR
$1.5B
| $225M | 0.01% |
5,159,629
+177,991
| +4% | +$7.71M |
|
1628
US Physical Therapy
USPH
$1.24B
| $224M | 0.01% |
2,022,594
-46,037
| -2% | -$5.25M |
|
1629
Editas Medicine
EDIT
$432M
| $224M | 0.01% |
5,444,010
-141,179
| -3% | -$7.74M |
|
|
SPR
1630
DELISTED
Spirit AeroSystems
SPR
| $223M | 0.01% |
5,055,588
+11,028
| +0.2% | +$462K |
|
|
LTC
1631
LTC Properties
LTC
$2.12B
| $223M | 0.01% |
7,038,865
-171,703
| -2% | -$6.14M |
|
1632
iShares Core Dividend Growth ETF
DGRO
$43.7B
| $223M | 0.01% |
4,435,017
-4,725,461
| -52% | -$245M |
|
1633
Westamerica Bancorp
WABC
$1.35B
| $222M | 0.01% |
3,954,349
+24,868
| +0.6% | +$1.4M |
|
1634
Artisan Partners
APAM
$3B
| $222M | 0.01% |
4,532,140
-1,739
| -0% | -$87.8K |
|
1635
La-Z-Boy
LZB
$1.66B
| $222M | 0.01% |
6,876,957
-358,834
| -5% | -$12.4M |
|
|
KRA
1636
DELISTED
Kraton Corporation
KRA
| $222M | 0.01% |
4,854,968
-187,710
| -4% | -$7.45M |
|
|
AXNX
1637
DELISTED
Axonics, Inc. Common Stock
AXNX
| $221M | 0.01% |
3,389,867
+404,439
| +14% | +$27.6M |
|
|
OPI
1638
DELISTED
Office Properties Income Trust
OPI
| $221M | 0.01% |
8,706,670
-240,055
| -3% | -$6.54M |
|
1639
BioCryst Pharmaceuticals
BCRX
$2.51B
| $220M | 0.01% |
15,330,858
-150,469
| -1% | -$2.37M |
|
1640
Agilon Health
AGL
$1.63B
| $220M | 0.01% |
336,169
+37,701
| +13% | +$32.2M |
|
1641
Cemex
CX
$16.3B
| $220M | 0.01% |
30,695,066
-5,220,926
| -15% | -$41.2M |
|
|
CSII
1642
DELISTED
Cardiovascular Systems, Inc.
CSII
| $220M | 0.01% |
6,697,591
-298,940
| -4% | -$11.2M |
|
1643
PBF Energy
PBF
$7.86B
| $219M | 0.01% |
16,904,787
-778,290
| -4% | -$8.07M |
|
1644
Howard Hughes
HHH
$3.91B
| $219M | 0.01% |
2,617,013
-117,300
| -4% | -$10.1M |
|
|
XLNX
1645
CALL
DELISTED
Xilinx Inc
XLNX
| $219M | 0.01% |
+1,449,800
| New | +$212M |
|
1646
The Greenbrier Companies
GBX
$1.43B
| $219M | 0.01% |
5,087,796
-216,362
| -4% | -$9.33M |
|
1647
StoneCo
STNE
$2.52B
| $218M | 0.01% |
6,291,167
-4,860,633
| -44% | -$252M |
|
1648
FuboTV Inc
FUBO
$276M
| $218M | 0.01% |
757,536
+26,654
| +4% | +$8.73M |
|
1649
Community Health Systems
CYH
$415M
| $218M | 0.01% |
18,614,283
-712,006
| -4% | -$9.29M |
|
|
TMX
1650
DELISTED
Terminix Global Holdings, Inc.
TMX
| $217M | 0.01% |
5,217,191
-1,309,007
| -20% | -$60.2M |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.